Yi-Nuan Zhang

Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up

Rui You, Yi-Jun Hua, You-Ping Liu et al. · Theranostics · 2017 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis

Rui You, Ying-Shu Cao, Pei‐Yu Huang et al. · Theranostics · 2017 · 71 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Proposal for a new risk classification system for nasopharyngeal carcinoma patients with post-radiation nasopharyngeal necrosis

Qi Yang, Xiong Zou, Rui You et al. · Oral Oncology · 2017 · 43 citations

Medicine, Oncology, Radiation Oncology +12

A Prognostic Bio-Model Based on SQSTM1 and N-Stage Identifies Nasopharyngeal Carcinoma Patients at High Risk of Metastasis for Additional Induction Chemotherapy

Qi Yang, Meng-Xia Zhang, Xiong Zou et al. · Clinical Cancer Research · 2017 · 33 citations

Medicine, Cancer Biology, Oncology +17

Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma

Mei Lin, Rui You, You-Ping Liu et al. · Oral Oncology · 2018 · 28 citations

Medicine, Oncology, Pharmacology +17